The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss ...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed treatment.

Exploring the Link Between Semaglutide and NAION For the new study, Pottegård and his team analyzed data from 44,517 people in Denmark and 16,860 people in Norway, all of whom were eligible for ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who don’t use the drug.

Bagsværd, Denmark, 21 October 2024— Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide ...

Trump's threat to levy tariffs on Denmark over Greenland could impact Ozempic costs. Learn how Trump's plans could disrupt the U.S. pharmaceutical industry.

Semaglutide use in diabetes patients is linked to a higher risk of NAION, a rare eye condition. A Danish-Norwegian study shows a low absolute risk despite significant association.